Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F W Strengers

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 1, 2006
[Episodes of angioedema in children with C1 esterase inhibitor deficiency]P F W Strengers
Developments in Biologicals|May 10, 2007
Is haemovigilance improving transfusion practice?--The european experienceP F W Strengers
Journal of Thrombosis and Haemostasis : JTH|August 7, 2016
Risks of inhibitors from recombinant factor VIII: a quarter of a century to reach the conclusionT Burnouf, P F W Strengers
Acta Anaesthesiologica Belgica|December 5, 2002
PPSB as first choice treatment in the reversal of oral anticoagulant therapyP F W Strengers, J C Drenth
Vox Sanguinis|September 16, 2010
Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized studyR Demeyere, S Gillardin, J Arnout, et al.
Vox Sanguinis|December 24, 2010
Haemovigilance: an effective tool for improving transfusion practiceR R P de Vries, J-C Faber, P F W Strengers, et al.
Vox Sanguinis|July 14, 2011
Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpuraJ W M van der Meer, R T van Beem, T Robak, et al.
Acta Anaesthesiologica Belgica|August 19, 2006
Emergency reversal of oral anticoagulation through PPSB-SD: the fastest procedure in BelgiumE Lavenne-Pardonge, M Amuli Itegwa, M Kalaai, et al.
European Heart Journal|October 26, 2002
Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionC de Zwaan, A H Kleine, J H C Diris, et al.
Clinical Immunology (Orlando, Fla.)|December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safetyJ J Hofstra, I Kleine Budde, E van Twuyver, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|August 1, 2006
[Episodes of angioedema in children with C1 esterase inhibitor deficiency]P F W Strengers
Developments in Biologicals|May 10, 2007
Is haemovigilance improving transfusion practice?--The european experienceP F W Strengers
Journal of Thrombosis and Haemostasis : JTH|August 7, 2016
Risks of inhibitors from recombinant factor VIII: a quarter of a century to reach the conclusionT Burnouf, P F W Strengers
Acta Anaesthesiologica Belgica|December 5, 2002
PPSB as first choice treatment in the reversal of oral anticoagulant therapyP F W Strengers, J C Drenth
Vox Sanguinis|September 16, 2010
Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized studyR Demeyere, S Gillardin, J Arnout, et al.
Vox Sanguinis|December 24, 2010
Haemovigilance: an effective tool for improving transfusion practiceR R P de Vries, J-C Faber, P F W Strengers, et al.
Vox Sanguinis|July 14, 2011
Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpuraJ W M van der Meer, R T van Beem, T Robak, et al.
Acta Anaesthesiologica Belgica|August 19, 2006
Emergency reversal of oral anticoagulation through PPSB-SD: the fastest procedure in BelgiumE Lavenne-Pardonge, M Amuli Itegwa, M Kalaai, et al.
European Heart Journal|October 26, 2002
Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionC de Zwaan, A H Kleine, J H C Diris, et al.
Clinical Immunology (Orlando, Fla.)|December 27, 2011
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safetyJ J Hofstra, I Kleine Budde, E van Twuyver, et al.
Pageof 2